Encompass Health's stock has declined recently, but its promising financial performance, particularly its ROE of 21%, shows its ability to generate profits efficiently. With higher net income growth than the industry average, the company's future growth potential seems strong.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing